ASX:MRR MinRex Resources (MRR) Stock Price, News & Analysis → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free MRR Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get MinRex Resources alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About MinRex ResourcesMinRex Resources Limited engages in the exploration and development of mineral properties. It focuses on the exploration of gold, silver, copper, lithium, tin, tantalum, and other base metal projects in New South Wales (NSW) and Western Australia. The company holds 70% interests in the Marble Bar North, Marble Bar South, Daltons, and Bamboo Creek gold projects in the East Pilbara region of Western Australia; and 100% interests in the Deflector Extended Gold project located at Gullewa in Western Australia. It also holds 7 exploration licenses in Mt Pleasant, Sofala, and Sunny Corner projects located in the Lachlan Fold Belt in NSW; and exploration licenses in lithium and tantalum deposits, as well as holds farm-in rights for 80% interest in EL7974 and EL7423 projects, and 90% interest in the exploration area of EL5964 project. The company was formerly known as MinRex Resources NL and changed its name to MinRex Resources Limited in January 2016. MinRex Resources Limited was incorporated in 2011 and is based in Perth, Australia.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> MRR Stock News HeadlinesFebruary 11, 2024 | msn.comTambourah Metals uncovers elevated lithium values at its Shaw River projectDecember 30, 2023 | morningstar.comMinRex Resources Ltd MRRApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.October 12, 2023 | msn.comAssays are coming: Tambourah wraps up drilling in Shaw River lithium huntOctober 10, 2023 | msn.comGoing for gold with a side of lithium: Tambourah wraps up first drilling at historic high-grade gold mine since 1898August 14, 2023 | benzinga.comMRR Brands: Simplifying the Process of Buying, Selling, and Funding Recurring Revenue BusinessesMarch 30, 2023 | msn.comTop 10 at 10: Battery deals, high grades and a monster REE upgradeMarch 20, 2023 | investing.comMinrex Resources Ltd (MRR)April 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.February 26, 2023 | au.finance.yahoo.comMinRex Resources Limited (MRR.AX)November 30, 2022 | afr.comMinRex Resources LimitedSee More Headlines Receive MRR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MinRex Resources and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/15/2018Today4/19/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorBasic Materials Industry Other Industrial Metals & Mining Sub-IndustryN/A Current SymbolASX:MRR CUSIPN/A CIKN/A Webwww.minrex.com.au Phone+61-8-94868806FaxN/AEmployees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-12,640,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-59.44% Return on Assets-38.15% Debt Debt-to-Equity Ratio0.59 Current Ratio54.17 Quick Ratio38.96 Sales & Book Value Annual Sales$4,063.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.00 Book ValueA$0.01 per share Price / BookN/AMiscellaneous Outstanding Shares1,080,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.24 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Ian ShackletonExploration Manager, Technical Director & DirectorMr. Johnathon BusingCompany SecretaryKey CompetitorsA-Cap EnergyASX:ACBAccelerate ResourcesASX:AX8Accent ResourcesASX:ACSACDC MetalsASX:ADCAclara ResourcesTSE:ARA.TOView All CompetitorsInsidersJames PearseSold 8,000,000 sharesTotal: $136,000.00 ($0.02/share)Ian ShackletonBought 3,600,000 shares on 10/5/2023Total: $57,600.00 ($0.02/share)Glenn WhiddonBought 20,000,000 shares on 9/12/2023Total: $300,000.00 ($0.02/share) MRR Stock Analysis - Frequently Asked Questions How were MinRex Resources' earnings last quarter? MinRex Resources Limited (ASX:MRR) posted its quarterly earnings data on Thursday, March, 15th. The company reported ($0.01) earnings per share (EPS) for the quarter. This page (ASX:MRR) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlace1970’s computer coder issues shocking A.I. warningTradeSmithHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MinRex Resources Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.